FDA Approval Outlook
The latest news about FDA Approval Outlook: headlines, AI summaries and the full story from every source.
- JPMorgan Increases Price Target for Xenon Pharmaceuticals
- UBS Upgrades Jazz Pharmaceuticals with Significant Price Target Increase
- UBS Upgrades Jazz Pharmaceuticals with Significant Price Target Increase
- Canaccord Maintains Buy Rating on Compass Therapeutics Despite Lowered Price Target
- Evolus Reports Q1 2026 Earnings and Strategic Updates